image
Biodexa Pharmaceuticals Plc BDRX
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 1.3
-5.67 %
$ 2.17 K
Market Cap
-0.02
P/E
BALANCE SHEET
14.8 M ASSETS
40.20%
Growth Rates
1Year 40.20%
3Years 4.60%
5Years -13.71%
7Years -15.79%
10Years -10.86%
6.46 M LIABILITIES
10.13%
Growth Rates
1Year 10.13%
3Years 37.94%
5Years -10.64%
7Years -10.95%
10Years 3.29%
8.32 M EQUITY
77.90%
Growth Rates
1Year 77.90%
3Years -7.32%
5Years -15.71%
7Years -18.44%
10Years -14.94%
BALANCE SHEET DECOMPOSITION
Balance Sheet Biodexa Pharmaceuticals Plc
image
Current Assets 8.81 M
Cash & Short-Term Investments 1.67 M
Receivables 715 K
Other Current Assets 6.43 M
Non-Current Assets 5.97 M
Long-Term Investments 0
PP&E 324 K
Other Non-Current Assets 5.65 M
11.29 %4.84 %43.48 %38.20 %Total Assets$14.8m
Current Liabilities 5.03 M
Accounts Payable 707 K
Short-Term Debt 609 K
Other Current Liabilities 3.72 M
Non-Current Liabilities 1.42 M
Long-Term Debt 118 K
Other Non-Current Liabilities 1.31 M
10.95 %9.43 %57.57 %20.22 %Total Liabilities$6.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 1.7 6.0 2.8 10.1 7.5 10.9 2.3 13.2 17.6 16.2 30.3 2.4 0.1
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.7 0.7 0.3 33 K 95 K 22 K 89 K 2.2 1.4 1.0 0.2 0.2 0
Inventory 0 (0.7) 1 1 (1.4) 1 0 0.9 0.8 0.5 0 0 0
Other Current Assets 6.4 1.1 0.4 0.6 0.3 2.8 3.2 2.2 2.5 2.7 1.1 1.5 1.0
Total Current Assets 8.8 7.0 4.7 11.8 9.3 13.7 5.6 18.6 22.3 20.3 31.6 4.1 1.1
PP&E 0.3 0.6 0.8 1.2 0.5 2.2 2.0 2.5 2.8 2.0 1.5 0.7 0.9
Intangible Assets 5.6 2.9 6 K 0 0 10.1 10.1 14.2 16.7 28.9 10.8 4 K 2 K
Goodwill 0 0 0 0 0 2.3 2.3 13.4 14.5 12.5 2.3 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 12 K 49 K
Other Long Term Assets 0 0 (0.8) (1.2) (0.5) 2.6 0.5 0.5 0.4 0.4 0.4 0.4 (0.9)
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0.2
Total Assets 14.8 10.5 5.5 12.9 9.8 30.9 20.4 49.2 56.7 64.0 46.7 5.2 2.2
LIABILITIES
Accounts Payable 0.7 0.3 0.3 0.5 0.3 0.7 0.3 2.3 3.3 2.3 1.0 0.5 0.6
Short Term Debt 0.6 0.2 0.2 0.1 0.2 0.4 0.4 0.4 0.5 0.4 0.5 1.2 0
Other Current Liabilities 2.2 5.0 1.3 1.2 2.4 4.4 1.8 5.7 5.5 6.4 1.4 0.6 4.5
Total Current Liabilities 5.0 5.6 1.9 1.8 3.0 5.7 2.5 8.4 9.3 9.1 2.8 2.3 5.1
Long Term Debt 0.1 0.3 0.5 0.6 60 K 5.7 0.9 6.2 1.6 1.5 1.5 2.1 2.2
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 1.3 0 0 469 50 K 0 0.2 0 0 6.5 0.4 0 (2.2)
Total Liabilities 6.5 5.9 2.4 2.5 3.1 11.3 3.5 14.5 11.0 17.2 4.7 4.4 7.3
EQUITY
Common Stock 6.7 1.2 1.1 98.5 K 63 K 23 K 3 K 3 K 2 K 2 K 1 K 0 0
Retained Earnings (150.4) (144.8) (135.3) (127.8) (122.4) (99.8) (89.7) (74.7) (59.1) (39.2) (29.2) (20.4) (17.2)
Other Accumulative Comprehensive Income/Loss 53.0 61.5 53.0 53.0 53.0 53.5 53.7 56.4 57.6 54.4 39.6 0.1 0
Total Equity 8.3 4.7 3.2 10.5 6.7 19.6 16.9 34.7 45.7 46.9 42.0 0.8 (5.1)
Total Liabilities and Equity 14.8 10.5 5.5 12.9 9.8 30.9 20.4 49.2 56.7 64.0 46.7 5.2 0
SHARES OUTSTANDING
Common Shares Outstanding 78 30 25 13 5 0 0 0 0 0 0 0